Intangibles, net - Cost Of Goods Sold (Details) $ in Thousands |
9 Months Ended |
|---|---|
|
Sep. 30, 2020
USD ($)
| |
| Beginning balance at January 1, 2020 | $ 7,377 |
| Ending balance at September 30, 2020 | 11,039 |
| Journey Medical Corporation [Member] | |
| Beginning balance at January 1, 2020 | 7,377 |
| Asset not yet placed in service | 4,727 |
| Acne product license acquisition | 4,727 |
| Amortization expense | (1,065) |
| Ending balance at September 30, 2020 | $ 11,039 |
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|